BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bradley JS, Garonzik SM, Forrest A, Bhavnani SM. Pharmacokinetics, pharmacodynamics, and Monte Carlo simulation: selecting the best antimicrobial dose to treat an infection. Pediatr Infect Dis J 2010;29:1043-6. [PMID: 20975453 DOI: 10.1097/INF.0b013e3181f42a53] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Patel K, Bunachita S, Agarwal AA, Bhamidipati A, Patel UK. A Comprehensive Overview of Antibiotic Selection and the Factors Affecting It. Cureus 2021;13:e13925. [PMID: 33868859 DOI: 10.7759/cureus.13925] [Reference Citation Analysis]
2 Donà D, Zingarella S, Gastaldi A, Lundin R, Perilongo G, Frigo AC, Hamdy RF, Zaoutis T, Da Dalt L, Giaquinto C. Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia. PLoS One 2018;13:e0193581. [PMID: 29489898 DOI: 10.1371/journal.pone.0193581] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
3 Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH, Moore MR. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25-e76. [PMID: 21880587 DOI: 10.1093/cid/cir531] [Cited by in Crossref: 686] [Cited by in F6Publishing: 595] [Article Influence: 62.4] [Reference Citation Analysis]
4 Lavi E, Breuer O. The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia. Curr Infect Dis Rep 2016;18:3. [PMID: 26715113 DOI: 10.1007/s11908-015-0509-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Busse D, Schaeftlein A, Solms A, Ilia L, Michelet R, Zeitlinger M, Huisinga W, Kloft C. Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Reponse Exemplified by Levofloxacin. Pharm Res 2021;38:381-95. [PMID: 33723793 DOI: 10.1007/s11095-021-02994-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Kaguelidou F, Turner MA, Choonara I, van den Anker J, Manzoni P, Alberti C, Langhendries JP, Jacqz-Aigrain E. Randomized controlled trials of antibiotics for neonatal infections: a systematic review. Br J Clin Pharmacol 2013;76:21-9. [PMID: 23488627 DOI: 10.1111/bcp.12113] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
7 Lepak AJ, Andes DR. Antifungal pharmacokinetics and pharmacodynamics. Cold Spring Harb Perspect Med 2014;5:a019653. [PMID: 25384765 DOI: 10.1101/cshperspect.a019653] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
8 Agrawal M, Rattan A. How to Treat Sepsis in the Background of Resistance?: Role of Pharmacodynamics / Pharmacokinetics in Treating Sepsis. Indian J Pediatr 2020;87:111-6. [PMID: 31933137 DOI: 10.1007/s12098-019-03153-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Srinivas SP, Goyal A, Talele DP, Mahadik S, Sudhir RR, Murthy PP, Ranganath S, Kompella UB, Padmanabhan P. Corneal epithelial permeability to fluorescein in humans by a multi-drop method. PLoS One 2018;13:e0198831. [PMID: 29920519 DOI: 10.1371/journal.pone.0198831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]